A commentary on changing infant death rates and a plea to use sudden infant death syndrome as a cause of death

  • Henry F. Krous

In his editorial entitled Changing Infant Death RatesDiagnostic Shift, Success Story, Or Both, Byard concludes that changes in rates away from sudden infant death syndrome (SIDS) towards another cause of death (COD) are appropriate [1]. Improved death scene investigations and autopsies leading to increased awareness of potential dangers imposed by infant sleep sites have been instrumental to the diagnostic shift occurring in cases of sudden unexpected infant death. Given abundant supportive data accumulating over the past few years, we certainly agree. But where do we go from here in order to bring about greater consensus and accuracy in establishing CODs in these cases?

Over the past four decades, the original definition of SIDS [2] has undergone several refinements focusing principally on mandating death scene investigations, circumstances of death, association with sleep, and certainty of the COD [3, 4, 5]. Yet, each subsequent iteration has remained exclusionary with respect to...


Sudden Infant Death Syndrome Sudden Infant Death Syndrome Case Ancillary Testing Death Scene Fatty Acid Oxidation Defect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Byard RW. Changing infant death rates—diagnostic shift, success story, or both? Forensic Sci Med Pathol. 2012; doi: 10.1007/s12024-012-9350-1.
  2. 2.
    Beckwith JB. Discussion of terminology and definition of the sudden infant death sydrome. In: Bergman AB, Beckwith JB, Ray CG, editors. Proceedings of the second international conference on the causes of sudden death in infants. Seattle: University of Washington Press; 1970. p. 14–22.Google Scholar
  3. 3.
    Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatric Pathol. 1991;11(5):677–84.CrossRefGoogle Scholar
  4. 4.
    Krous HF, Beckwith JB, Byard RW, Rognum TO, Bajanowski T, Corey T, et al. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics. 2004;114(1):234–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Randall B, Donelan K, Koponen M, Sens MA, Krous HF. Application of a classification system focusing on potential asphyxia for cases of sudden unexpected infant death. Forensic Sci Med Pathol. 2012;8(1):34–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Krous HF. Sudden unexpected death in infancy and the dilemma of defining the sudden infant death syndrome. Curr Pediatric Rev. 2010;6:5–12.CrossRefGoogle Scholar
  7. 7.
    Trachtenberg FL, Haas EA, Kinney HC, Stanley C, Krous HF. Risk factor changes for Sudden infant death syndrome after initiation of back-to-sleep campaign. Pediatrics. 2012;129(4):630–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Kinney HC, Thach BT. The sudden infant death syndrome. N Eng J Med. 2009;361(8):795–805.CrossRefGoogle Scholar
  9. 9.
    Kinney HC. Brainstem mechanisms underlying the sudden infant death syndrome: evidence from human pathologic studies. Dev Psychobiol. 2009;51(3):223–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Froggatt P, Lynas MA, Marshall TK. Sudden death in babies: epidemiology. Am J Cardiol. 1968;22(4):457–68.PubMedCrossRefGoogle Scholar
  11. 11.
    Broadbelt KG, Rivera KD, Paterson DS, Duncan JR, Trachtenberg FL, Paulo JA et al. Brainstem deficiency of the 14-3-3 regulator of serotonin synthesis: a proteomics analysis in the sudden infant death syndrome. Mol Cell Proteomics. 2012; doi: 10.1074/mcp.M111.009530.
  12. 12.
    Duncan JR, Paterson DS, Hoffman JM, Mokler DJ, Borenstein NS, Belliveau RA, et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA. 2010;303(5):430–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Kinney HC, Randall LL, Sleeper LA, Willinger M, Belliveau RA, Zec N, et al. Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome. J Neuropathol Exp Neurol. 2003;62(11):1178–91.PubMedGoogle Scholar
  14. 14.
    Kinney HC. Neuropathology provides new insight in the pathogenesis of the sudden infant death syndrome. Acta Neuropathol. 2009;117(3):247–55.PubMedCrossRefGoogle Scholar
  15. 15.
    Broadbelt KG, Paterson DS, Belliveau RA, Trachtenberg FL, Haas EA, Stanley C, et al. Decreased GABAA receptor binding in the medullary serotonergic system in the sudden infant death syndrome. J Neuropathol Exp Neurol. 2011;70(9):799–810.PubMedGoogle Scholar
  16. 16.
    Ackerman MJ. State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young. Pacing Clin Electrophysiol. 2009;32(Suppl 2):S86–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001;286(18):2264–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Tester DJ, Ackerman MJ. Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. Ann Rev Med. 2009;60:69–84.PubMedCrossRefGoogle Scholar
  19. 19.
    Van Norstrand DW, Asimaki A, Rubinos C, Dolmatova E, Srinivas M, Tester DJ, et al. Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death. Circulation. 2012;125:474–81.PubMedCrossRefGoogle Scholar
  20. 20.
    Tester DJ, Tan BH, Medeiros-Domingo A, Song C, Makielski JC, Ackerman MJ. Loss-of-function mutations in the KCNJ8-encoded Kir6.1K(ATP) channel and sudden infant death syndrome. Circ Cardiovasc Genet. 2011;4(5):510–5.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of PathologyRady Children’s HospitalSan DiegoUSA

Personalised recommendations